- Home
- ATYR vs PBFS Comparison
ATYR vs PBFS Comparison
Compare ATYR & PBFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- PBFS
- Stock Information
- Founded
- ATYR 2005
- PBFS 1889
- Country
- ATYR United States
- PBFS United States
- Employees
- ATYR N/A
- PBFS N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- PBFS Banks
- Sector
- ATYR Health Care
- PBFS Finance
- Exchange
- ATYR Nasdaq
- PBFS Nasdaq
- Market Cap
- ATYR 330.7M
- PBFS 309.6M
- IPO Year
- ATYR 2015
- PBFS N/A
- Fundamental
- Price
- ATYR $3.70
- PBFS $11.89
- Analyst Decision
- ATYR Strong Buy
- PBFS
- Analyst Count
- ATYR 6
- PBFS 0
- Target Price
- ATYR $18.60
- PBFS N/A
- AVG Volume (30 Days)
- ATYR 1.9M
- PBFS 26.6K
- Earning Date
- ATYR 03-13-2025
- PBFS 05-12-2025
- Dividend Yield
- ATYR N/A
- PBFS N/A
- EPS Growth
- ATYR N/A
- PBFS 11.77
- EPS
- ATYR N/A
- PBFS 0.76
- Revenue
- ATYR $235,000.00
- PBFS $88,118,000.00
- Revenue This Year
- ATYR $1,387.23
- PBFS N/A
- Revenue Next Year
- ATYR $873.22
- PBFS N/A
- P/E Ratio
- ATYR N/A
- PBFS $15.61
- Revenue Growth
- ATYR N/A
- PBFS 21.67
- 52 Week Low
- ATYR $1.42
- PBFS $8.76
- 52 Week High
- ATYR $4.66
- PBFS $12.20
- Technical
- Relative Strength Index (RSI)
- ATYR 54.37
- PBFS 54.69
- Support Level
- ATYR $2.98
- PBFS $11.77
- Resistance Level
- ATYR $4.32
- PBFS $12.04
- Average True Range (ATR)
- ATYR 0.39
- PBFS 0.24
- MACD
- ATYR 0.06
- PBFS -0.01
- Stochastic Oscillator
- ATYR 72.14
- PBFS 54.24
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.